case study_Corning

case study_Corning - no. 2-0020 Corning Microarray...

Info iconThis preview shows pages 1–3. Sign up to view the full content.

View Full Document Right Arrow Icon
no. 2-0020 This case was written by Professor Chris Trimble and Gautam Bellur (T’03) of the Tuck School of Business at Dartmouth. This research was sponsored by the William F. Achtmeyer Center for Global Leadership. It was written for class discussion and not to illustrate effective or ineffective management practices. Version: 4/11/03. © 2003 Trustees of Dartmouth College. All rights reserved. To order additional copies please call: 603-646-0898. Corning Microarray Technologies Greg Brown, general manager of Corning Microarray Technologies (CMT), finished delivering the bad news to his team. Through the first half of 2001, demand had plunged in the telecommunications sector, which accounted for 73% of Corning’s revenue. As a result, Corning could not sustain funding for the nascent CMT venture. He instructed the group that they would have to identify options for keeping the program alive with half or less of its current budget. Mr. Brown knew that few situations strained the cohesiveness of a management team like formulating plans for severe budget cuts. Still, the team had strengthened dramatically since he had inherited the venture, rife with conflict, in November 1999. Because he had commitments to travel for the following two weeks, he left them to work on their own, expecting detailed proposals upon his return. Opportunity: Meeting the Needs of Genetic Researchers In June 2000, the scientific community reached a momentous milestone, the complete mapping of the human genome. But even before this breakthrough, molecular biologists conducted new genetic experiments. They started with organisms with simpler genetic codes, such as yeast, and worked towards more complex genomes and partial strands of human DNA. Once scientists had completely mapped the human genome, literally millions of new tests were possible. There was no scientific field ready to grow as explosively as genomics. Researchers sought new knowledge about the genetic basis of life, and in particular, genetic markers for diseases. They anticipated advancing to experiments with specific subsets of genes known to be related to a particular disease. They foresaw a revolution in medical therapies. Genetic experiments involved measuring the magnitude of DNA interactions. Measurements were always comparative, between an experimental sample and a control sample. Due to the complexity of genetics and the imperfect nature of the laboratory apparatus, experiments were run multiple times, and conclusions drawn on statistical inference. The high standards of proof expected in the physical sciences
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Corning Microarray Technologies no. 2-0020 Tuck School of Business at Dartmouth – William F. Achtmeyer Center for Global Leadership 2 were not possible in genetic research. Experimentation generated tremendous volumes of data, and was computationally intensive.
Background image of page 2
Image of page 3
This is the end of the preview. Sign up to access the rest of the document.

Page1 / 25

case study_Corning - no. 2-0020 Corning Microarray...

This preview shows document pages 1 - 3. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online